Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA, and CEA in carcinomas of the colon

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2325-2331

  Von Kleist, S ^a   Hesse, Y ^a   Kananeeh, H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CA 19 9; CA 242; CEA; Colon cancer; TPA; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; COLON CANCER; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; HUMANS; MIDDLE AGED; PEPTIDES; SENSITIVITY AND SPECIFICITY; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0029814951     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. von Kleist S: What's new in tumor markers? Pathol Res Pract 183: 95-99, 1988.
2. von Kleist S, Bombardieri E, Gion M, Hertel A, Hör G, Noujaim A, Schwartz M, Senekowitsch R, Wittekind C: Immunodiagnosis of tumors. Europ J Cancer 29: 1622-1630, 1993.
3. Sugarbaker PH, Gianola FJ, Dwyer A, Neuman NR: A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 102: 79-87, 1987.
4. Minton J, Chevinsky AH: CEA directed second-look surgery for colon and rectal cancer. Ann Chir Gynaecol 78: 32-37, 1989.
5. Koprowski H, Herlyn, M, Steplewski Z: Specific antigen in serum of patients with colon cancer. Science 212: 534, 1981.
6. Lüttgens M, Schlegel G: CEA und TPA in der klinischen Tumordiagnostik, insbesondere des Mammakarzinoms. Tumor Diagn and Ther 2: 63-77, 1980.
7. Johansson C, Nilsson O, Lindholm L: Comparison of serological expression of different epitopes on the CA 50-carrying antigen, CanAg. Int J Cancer 48: 757-763, 1991.
8. von Kleist S: The clinical value of tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: A critical comparison. Int J Biol Markers 1: 3-8, 1986.
9. Szmymendera J, Nowacki M, Kozlowi CZ, Gudzinska I et al: Value of serum levels of carcinoembryonic antigen, Gica or CA 19/9 for preoperative staging and postoperativ monitoring of patients with colorectal cancer. Dis Colon Rectum 28: 895-899, 1985.
10. Roberts PJ: Tumor markers in colorectal cancer. Scand J Gastroenterol 23: 50-58, 1988.
11. Nilsson O, Johansson C, Glimelius B, Persson B, N0gard-Pedersen B, Andren-Sandberg A, Lindholm L: Sensitivity and specificity of CA 242 in gastrointestinal cancer. A comparison with CEA, CA 50 and CA 19/9. Br J Cancer 65: 215-221, 1992.
12. Carpelan-Holmström, Haglund C, Kunsela P, Jarvinen H, Roberts PJ: Preoperative CEA serum levels and CA 242 in patients with colorectal cancer. Br J Cancer 71: 868-872, 1995.
13. Linmark, G, Bergstrom R, Pahlman L, Glimelius B: The association of preoperative serum tumor markers with Dukes' stage and survival in colorectal cancer. Br J Cancer 71: 1090-1094, 1995.
14. Safi F, Beger HG, Bittner R, Buchler M, Kautzberger W: CA 19/9 and pancreatic adenocarcinoma. Cancer 57: 779-783, 1986.
15. Sakahara H, Endo K, Nakajima K, Nakashima T, Koizumi M, et al: Serum CA 19/9 concentrations and computed tomography findings in patients with pancreatic carcinoma. Cancer 57: 1324-1326, 1986.
16. Kawa S, Tokoo M, Hasebe O, Hayashi K, Imai H, Ogushi H, Kiyosawa K, Furuka S, Homma T: Comparative study of CA 242 and CA 19/9 for the diagnosis of pancreatic cancer. Br J Cancer 70: 481-486, 1994.
17. Haglund C, Lundin J, Kunsela P, Roberts PJ: CA 242, a new tumor marker for pancreatic cancer: A comparison with CA 19/9, CA 50 and CEA. Br J Cancer 70: 487-492, 1994.
18. Hall NR, Finan PJ, Stephenson BM, Purves DA, Cooper EH: The role of CA 242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer 70: 549-553, 1994.
19. Kunsela P, Haglund C, Roberts PJ: Comparison of a new tumor marker CA 242 with CA19/9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer 63: 636-640, 1991.
20. Ward U, Primrose JN, Finan PJ, Perren TJ, Selby P, Purves DA, Cooper EH: The use of tumor markers CEA,CA195 and CA 242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br J Cancer 67: 1132-1135, 1993.